Back

Acute coronary syndrome vs chronic coronary syndrome drug-eluting balloon PCI: a lesion-level analysis of predictors and outcomes of target lesion failure

29 August 2026 (11:30 - 11:45)
Organised by: Logo
Congress Presentation Part of: Optimising strategies in acute coronary syndromes Primary Percutaneous Coronary Intervention (PCI) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Lucas Hamann

Algarve University Hospital Center, Faro (Portugal)

3 More presentations in this session

Presentation thumbnail
Underutilization of invasive management and its association with long-term outcomes in cancer patients with acute myocardial infarction
Assistant Professor W. Han (Shanghai, CN)
Abstract
Presentation thumbnail
Randomized trial of deferred stenting with apixaban in high thrombus burden stemi using 3d echocardiography
Professor I. Shehata (Zagazig, EG)
Abstract
Presentation thumbnail
Invasive vs. conservative management in nonagenarians with acute coronary syndrome: a systematic review and meta-analysis
Doctor P. Vlachakis (Athens, GR)
Abstract

Access the full session

Session thumbnail
Optimising strategies in acute coronary syndromes

The Event

Event poster

ESC Congress 2026

29 August 2026 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Lesion preparation as an independent determinant of outcomes after drug-coated balloon angioplasty: evidence from clinical, angiographic and functional assessment in observational cohort
19 February 2026
thumbnail
Congress Presentation
Acute heart failure and acute coronary syndrome: not uncommon duo and dangerous.
8 March 2024
thumbnail
Congress Presentation
Characteristics of non-culprit plaques in acute coronary syndrome patients with previous plaque disruption at the culprit lesion
31 August 2019
thumbnail
Congress Presentation
Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources